Drug discovery is becoming slower and more expensive, but collaboration, and open science can change that. In this new op-ed, Conscience CEO Peng Fu and @estrid-j.bsky.social argue that the real breakthroughs will come from rethinking how science gets done.
š www.ddw-online.com/from-risk-to...
Peng Fu, CEO, and Estrid Jakobsen, Communications Lead at Conscience, explore how creativity and open science are transforming drug discovery.
